0 NASDAQ Companies - January 7, 2019Microbot Medical Announces FDA Pre-Submission Milestones for 2019Regulatory Pre-Submission of the Self-Cleaning Shunt (SCS™) Remains the Primary Operational Objective HINGHAM, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) — […]Read More
0 NASDAQ Companies - January 7, 2019Verrica Appoints Neil D. DeHenes as Vice President of Distribution, Trade and Channel StrategyWEST CHESTER, Pa., Jan. 07, 2019 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on […]Read More
0 NASDAQ Companies - January 7, 2019Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical ResearchersREDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — The LUNAR assay, a new blood-based assay intended to detect early-stage […]Read More
0 NASDAQ Companies - January 7, 2019Retrophin Provides Corporate Update and 2019 OutlookTop-line readout of pivotal FORT Study in PKAN expected 3Q19 SAN DIEGO, Jan. 07, 2019 (GLOBE NEWSWIRE) — Retrophin, Inc. […]Read More
0 NASDAQ Companies - January 7, 2019Merus Announces IND Clearance for MCLA-145MCLA-145 is a full-length human bispecific antibody binding to PD-L1 and CD137 UTRECHT, The Netherlands, Jan. 07, 2019 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - January 7, 2019Cyclacel Pharmaceuticals Reviews 2018 Achievements and Announces Key Business Objectives for 2019BERKELEY HEIGHTS, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]Read More
0 NASDAQ Companies - January 7, 2019AMAG Pharmaceuticals Announces Preliminary 2018 Financial Results and Provides 2019 Financial GuidanceAchieves 2018 revenue of between $471 million and $476 million, including approximately 28% growth in Feraheme® (ferumoxytol injection) sales Acquisition […]Read More
0 NASDAQ Companies - January 7, 2019Cara Therapeutics Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™ (CR845/ difelikefalin) Injection in Hemodialysis Patients with PruritusTop-line Data Readout Expected in Q2, 2019 STAMFORD, Conn., Jan. 07, 2019 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a […]Read More
0 NASDAQ Companies - January 7, 2019Akoustis Announces Order for 5.2 GHz BAW RF Filters from Second WiFi SoC Customer– AKF-1252 XBAW Filter to be Evaluated for Reference Design in 802.11ax Tri-Band WiFi CPE Platforms – – Marks Third […]Read More
0 TSX News - January 7, 2019Husky Reminds MEG Energy Shareholders to Tender Well in Advance of January 16 DeadlineCALGARY, Alberta, Jan. 07, 2019 (GLOBE NEWSWIRE) — Husky Energy (TSX:HSE) reminds MEG Energy shareholders to tender their shares immediately […]Read More